Your browser doesn't support javascript.
loading
FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways.
Dixit, Garima; Gonzalez-Bosquet, Jesus; Skurski, Joseph; Devor, Eric J; Dickerson, Erin B; Nothnick, Warren B; Issuree, Priya D; Leslie, Kimberly K; Maretzky, Thorsten.
Afiliación
  • Dixit G; Inflammation Program, University of Iowa, Iowa City, Iowa, USA.
  • Gonzalez-Bosquet J; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Skurski J; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA.
  • Devor EJ; Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Dickerson EB; Inflammation Program, University of Iowa, Iowa City, Iowa, USA.
  • Nothnick WB; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Issuree PD; Immunology Graduate Program, University of Iowa, Iowa City, Iowa, USA.
  • Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA.
  • Maretzky T; Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Clin Transl Med ; 13(5): e1223, 2023 05.
Article en En | MEDLINE | ID: mdl-37165578

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Clin Transl Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Clin Transl Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos